Chris Hillis: Newly Updated Choosing Wisely Canada – Hematology Recommendations
Chris Hillis, Vice President Oncology Interim and JHCC Site Executive,Chief of Oncology at Hamilton Health Sciences, Associate Professor at McMaster University Hamilton Ontario Canada, shared a post on LinkedIn:
“I’m proud to spotlight the newly updated Choosing Wisely Canada – Hematology recommendations. These evidence-based guidance developed by the Canadian Hematology Society to support thoughtful, high-value hematology care. These recommendations help clinicians and patients question practices that may not improve care and could cause harm or unnecessary cost.
Highlights include: judicious use of IVIG, evidence-based transfusion practice, and a personal favourite (vendetta): to not do an FNA when lymphoma is suspected.
I encourage colleagues across disciplines to explore these recommendations and think critically about how they apply in your practice settings.
Together, we can ensure hematology care that is safer, smarter, and more sustainable.
Thanks to Mohammad R. for leading the update.”
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals
-
Feb 26, 2026, 14:37Inflammatory-Coagulation Cascade Interactions in Trauma-Induced Coagulopathy – JTH
-
Feb 26, 2026, 14:36Tareq Abadl: Protective Role of Sickle Cell Trait in Malaria
-
Feb 26, 2026, 14:33Nita Radhakrishnan: Strengthening Comprehensive Thalassemia Care at UP HEMATOCON
-
Feb 26, 2026, 12:05Anirban Sen Gupta: PlateChek Links Platelet Status to Hemostasis Outcomes in Whole Blood
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market